和元生物
(688238)
| 流通市值：43.53亿 | | | 总市值：44.07亿 |
| 流通股本：6.41亿 | | | 总股本：6.49亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 150,737,228.45 | 292,589,938.14 | 238,694,510.77 | 287,005,381.69 |
| 交易性金融资产 | 50,218,826.4 | - | 50,002,454.99 | - |
| 应收票据及应收账款 | 95,890,358.59 | 93,591,540.39 | 82,023,646.74 | 84,587,907.92 |
| 其中：应收票据 | - | - | 1,453,500 | 1,453,500 |
| 应收账款 | 95,890,358.59 | 93,591,540.39 | 80,570,146.74 | 83,134,407.92 |
| 应收款项融资 | - | - | - | 1,164,000 |
| 预付款项 | 6,769,905.96 | 5,823,386.73 | 8,923,964.84 | 7,091,200.53 |
| 其他应收款合计 | 3,079,962.24 | 2,055,301.3 | 2,426,851.43 | 697,727.6 |
| 存货 | 77,202,295.45 | 69,121,723.17 | 78,766,913.8 | 77,515,566.23 |
| 合同资产 | 31,315,044.42 | 26,507,558.14 | 23,685,961.98 | 24,500,087.64 |
| 其他流动资产 | 58,178,426.44 | 57,465,951.75 | 52,327,773.1 | 46,673,382.42 |
| 流动资产合计 | 473,392,047.95 | 547,155,399.62 | 536,852,077.65 | 529,235,254.03 |
| 非流动资产: | | | | |
| 长期股权投资 | 58,012,117.66 | 56,757,899.03 | 62,567,560.19 | 62,827,788.45 |
| 其他权益工具投资 | 70,669,912.19 | 70,669,912.19 | 64,669,912.19 | 75,648,571.28 |
| 固定资产 | 1,284,470,165.01 | 1,304,329,655.28 | 1,301,109,834.84 | 1,313,090,241.08 |
| 在建工程 | 11,738,255.49 | 10,612,081.12 | 49,536,746.71 | 52,100,067.03 |
| 使用权资产 | 11,844,286.63 | 13,063,322.53 | 14,282,358.43 | 823,729.05 |
| 无形资产 | 55,464,731.14 | 55,834,555.29 | 53,787,342.47 | 54,095,816.63 |
| 长期待摊费用 | 1,511,842.2 | 2,191,975.59 | 2,872,108.98 | 3,552,242.37 |
| 递延所得税资产 | 31,074,888.09 | 31,177,347.27 | 31,293,770.11 | 28,079,134.75 |
| 非流动资产合计 | 1,524,786,198.41 | 1,544,636,748.3 | 1,580,119,633.92 | 1,590,217,590.64 |
| 资产总计 | 1,998,178,246.36 | 2,091,792,147.92 | 2,116,971,711.57 | 2,119,452,844.67 |
| 流动负债: | | | | |
| 短期借款 | 165,086,028.05 | 250,166,986.12 | 244,653,985.94 | 204,713,214.99 |
| 应付票据及应付账款 | 64,746,399.68 | 95,295,914.06 | 106,264,585.82 | 109,210,149.68 |
| 应付账款 | 64,746,399.68 | 95,295,914.06 | 106,264,585.82 | 109,210,149.68 |
| 合同负债 | 33,526,278.76 | 32,523,234.97 | 34,077,482.97 | 26,220,686.81 |
| 应付职工薪酬 | 21,924,155.46 | 27,145,681.48 | 12,419,210.53 | 10,970,416.83 |
| 应交税费 | 3,068,786.58 | 4,321,978.84 | 2,917,039.05 | 2,505,985.07 |
| 其他应付款合计 | 8,059,728.57 | 7,679,416.01 | 7,862,997.02 | 7,396,157.34 |
| 一年内到期的非流动负债 | 70,393,973.54 | 24,856,079.05 | 20,308,131.83 | 17,795,506.95 |
| 其他流动负债 | 2,100,313.25 | 1,964,270.18 | 2,077,225.79 | 1,596,447.67 |
| 流动负债合计 | 368,905,663.89 | 443,953,560.71 | 430,580,658.95 | 380,408,565.34 |
| 非流动负债: | | | | |
| 长期借款 | 173,870,500 | 136,354,000 | 110,587,500 | 118,071,000 |
| 租赁负债 | 7,602,688.71 | 9,064,996.85 | 10,516,197.9 | 654,705.34 |
| 预计负债 | 17,757,540.68 | 19,853,890.18 | 21,375,121.5 | 22,502,534.84 |
| 递延收益 | 69,688,143.64 | 71,194,705.29 | 59,070,735.82 | 60,417,675.7 |
| 递延所得税负债 | 2,968,309.44 | 3,265,830.63 | 3,570,589.61 | 205,932.27 |
| 非流动负债合计 | 271,887,182.47 | 239,733,422.95 | 205,120,144.83 | 201,851,848.15 |
| 负债合计 | 640,792,846.36 | 683,686,983.66 | 635,700,803.78 | 582,260,413.49 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 649,036,700 | 649,036,700 | 649,036,700 | 649,036,700 |
| 资本公积 | 1,450,523,593.38 | 1,449,738,623.83 | 1,449,998,866.09 | 1,448,344,603.57 |
| 减:库存股 | 99,998,582.03 | 99,998,582.03 | 99,943,885.46 | 99,943,885.46 |
| 其他综合收益 | 265,383.02 | 355,763.15 | 413,942.35 | 1,193,983.62 |
| 盈余公积 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 | 9,313,913.89 |
| 未分配利润 | -653,433,762.62 | -600,348,938.21 | -527,399,832.49 | -470,597,121.72 |
| 归属于母公司股东权益合计 | 1,355,707,245.64 | 1,408,097,480.63 | 1,481,419,704.38 | 1,537,348,193.9 |
| 少数股东权益 | 1,678,154.36 | 7,683.63 | -148,796.59 | -155,762.72 |
| 股东权益合计 | 1,357,385,400 | 1,408,105,164.26 | 1,481,270,907.79 | 1,537,192,431.18 |
| 负债和股东权益合计 | 1,998,178,246.36 | 2,091,792,147.92 | 2,116,971,711.57 | 2,119,452,844.67 |
| 公告日期 | 2026-04-28 | 2026-04-21 | 2025-10-28 | 2025-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |